Skip to main content
Log in

Do children and adults differ in survival from medulloblastoma? A study from the SEER registry

  • Clinical Study - Patient Study
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

Studies investigating whether adults have diminished survival from medulloblastoma (MB) compared with children have yielded conflicting results. We sought to determine in a population-based registry whether adults and children with MB differ in survival, and to examine whether dissimilar use of chemotherapy might contribute to any disparity. 1,226 MB subjects were identified using the Surveillance Epidemiology and End Results (SEER-9) registry (1973–2002) and survival analysis performed. MB was defined strictly to exclude non-cerebellar primitive neuro-ectodermal tumors. Patients were stratified by age at diagnosis: <3 years (infants), 3–17 years (children) and ≥18 years (adults). Because the SEER-9 registry lacks treatment data, a subset of 142 patients were identified using the San Francisco-Oakland SEER registry (1988–2003) and additional analyses performed. There was no significant difference in survival between children and adults with MB in either the SEER-9 (P = 0.17) or SFO (P = 0.89) cohorts but infants fared worse compared to both children (P < 0.01) and adults (P < 0.01). In the SFO sample, children and adults who received chemotherapy plus radiation therapy (XRT) did not differ in survival. Among patients treated with XRT alone, children showed increased survival (P = 0.04) compared with adults. Children and adults with MB do not differ with respect to overall survival, yet infants fare significantly worse. For children and adults with MB treated with both XRT and chemotherapy, we could not demonstrate a survival difference. Similar outcomes between adult and childhood MB may justify inclusion of adults in pediatric cooperative trials for MB.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Roberts RO, Lynch CF, Jones MP, Hart MN (1991) Medulloblastoma: a population-based study of 532 cases. J Neuropathol Exp Neurol 50:134–144. doi:10.1097/00005072-199103000-00005

    Article  CAS  PubMed  Google Scholar 

  2. Duffner PK, Cohen ME, Myers MH, Heise HW (1986) Survival of children with brain tumors: SEER Program 1973–1980. Neurology 36:597–601

    Article  CAS  PubMed  Google Scholar 

  3. Lai R (2008) Survival of patients with adult medulloblastoma: a population-based study. Cancer 112:1568–1574. doi:10.1002/cncr.23329

    Article  PubMed  Google Scholar 

  4. Le QT, Weil MD, Wara WM et al (1997) Adult medulloblastoma: an analysis of survival and prognostic factors. Cancer J Sci Am 3:238–245

    CAS  PubMed  Google Scholar 

  5. Peterson K, Walker RW (1995) Medulloblastoma/primitive neuroectodermal tumor in 45 adults. Neurology 45:440–442

    Article  CAS  PubMed  Google Scholar 

  6. Prados MD, Warnick RE, Wara WM et al (1995) Medulloblastoma in adults. Int J Radiat Oncol Biol Phys 32:1145–1152. doi:10.1016/0360-3016(94)00476-2

    Article  CAS  PubMed  Google Scholar 

  7. Greenberg HS, Chamberlain MC, Glantz MJ, Wang S (2001) Adult medulloblastoma: multiagent chemotherapy. Neurooncology 3:29–34. doi:10.1215/15228517-3-1-29

    CAS  Google Scholar 

  8. Padovani L, Sunyach MP, Perol D et al (2007) Common strategy for adult and pediatric medulloblastoma: a multicenter series of 253 adults. Int J Radiat Oncol Biol Phys 68:433–440. doi:10.1016/j.ijrobp.2006.12.030

    Article  PubMed  Google Scholar 

  9. Brandes AA, Franceschi E, Tosoni A et al (2007) Long-term results of a prospective study on the treatment of medulloblastoma in adults. Cancer 110:2035–2041. doi:10.1002/cncr.23003

    Article  PubMed  Google Scholar 

  10. Duffner PK, Horowitz ME, Krischer JP et al (1993) Postoperative chemotherapy and delayed radiation in children les than three years of age with malignant brain tumors. N Engl J Med 328:1725–1731. doi:10.1056/NEJM199306173282401

    Article  CAS  PubMed  Google Scholar 

  11. Evans AE, Jenkin RD, Sposto R et al (1990) The treatment of medulloblastoma, results of a prospective randomized trial of radiation therapy with and without CCNU, vincristine, and prednisone. J Neurosurg 72:572–582

    Article  CAS  PubMed  Google Scholar 

  12. Packer RJ, Sutton LN, Goldwein JW et al (1991) Improved survival with the use of adjuvant chemotherapy in the treatment of medulloblastoma. J Neurosurg 74:433–440

    Article  CAS  PubMed  Google Scholar 

  13. Packer RJ, Sutton LN, Elterman R (1994) Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy. J Neurosurg 81:690–698

    Article  CAS  PubMed  Google Scholar 

  14. Pomeroy SL, Tamayo P, Gaasenbeek M et al (2002) Prediction of central nervous system embryonal tumour outcome based on gene expression. Nature 415:436–442. doi:10.1038/415436a

    Article  CAS  PubMed  Google Scholar 

  15. Cress RD, Zaslavsky AM, West DW (2003) Completeness of information on adjuvant therapies for colorectal cancer in population-based cancer registries. Med Care 41:1006–1012. doi:10.1097/01.MLR.0000083740.12949.88

    Article  PubMed  Google Scholar 

  16. CBTRUS (2005) Statistical report: primary brain tumors in the United States, 1998–2002. Published by the Central Brain Tumor Registry of the United States

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Paul Graham Fisher.

Additional information

Dr. Curran was supported by the Stanford University Medical Scholars Program and the Child Neurology Foundation.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Curran, E.K., Le, G.M., Sainani, K.L. et al. Do children and adults differ in survival from medulloblastoma? A study from the SEER registry. J Neurooncol 95, 81–85 (2009). https://doi.org/10.1007/s11060-009-9894-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11060-009-9894-4

Keywords

Navigation